Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Clinical trial NCT00559988 · TERMINATED

Trial details

NCT number: NCT00559988
Sponsor: Biotronik, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Atrial Fibrillation Atrial Flutter Stroke Embolism, Systemic Arterial Major Bleeding

Start date: 2008-02-01
Primary completion: 2013-06-01
Enrollment: 2718

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.